174 related articles for article (PubMed ID: 38458796)
1. Association between long-term use of calcium channel blockers (CCB) and the risk of breast cancer: a retrospective longitudinal observational study protocol.
Ho C; Ha NT; Youens D; Abhayaratna WP; Bulsara MK; Hughes JD; Mishra G; Pearson SA; Preen DB; Reid CM; Ruiter R; Saunders CM; Stricker BH; van Rooij FJA; Wright C; Moorin R
BMJ Open; 2024 Mar; 14(3):e080982. PubMed ID: 38458796
[TBL] [Abstract][Full Text] [Related]
2. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
Raebel MA; Zeng C; Cheetham TC; Smith DH; Feigelson HS; Carroll NM; Goddard K; Tavel HM; Boudreau DM; Shetterly S; Xu S
Am J Epidemiol; 2017 Feb; 185(4):264-273. PubMed ID: 28186527
[TBL] [Abstract][Full Text] [Related]
3. Association between calcium channel blockers and breast cancer: a meta-analysis of observational studies.
Chen Q; Zhang Q; Zhong F; Guo S; Jin Z; Shi W; Chen C; He J
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):711-8. PubMed ID: 24829113
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
Lu Y; Van Zandt M; Liu Y; Li J; Wang X; Chen Y; Chen Z; Cho J; Dorajoo SR; Feng M; Hsu MH; Hsu JC; Iqbal U; Jonnagaddala J; Li YC; Liaw ST; Lim HS; Ngiam KY; Nguyen PA; Park RW; Pratt N; Reich C; Rhee SY; Sathappan SMK; Shin SJ; Tan HX; You SC; Zhang X; Krumholz HM; Suchard MA; Xu H
JAMA Netw Open; 2022 Mar; 5(3):e223877. PubMed ID: 35323951
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers and the incidence of breast and prostate cancer: A meta-analysis.
Thakur AA; Wang X; Garcia-Betancourt MM; Forse RA
J Clin Pharm Ther; 2018 Aug; 43(4):519-529. PubMed ID: 29656432
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).
Grimaldi-Bensouda L; Klungel O; Kurz X; de Groot MC; Maciel Afonso AS; de Bruin ML; Reynolds R; Rossignol M
BMJ Open; 2016 Jan; 6(1):e009147. PubMed ID: 26747033
[TBL] [Abstract][Full Text] [Related]
7. The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies.
Rotshild V; Azoulay L; Zarifeh M; Masarwa R; Hirsh-Raccah B; Perlman A; Muszkat M; Matok I
Drug Saf; 2018 Jun; 41(6):555-564. PubMed ID: 29484611
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Protocol for a mixed-method study to inform the feasibility of undertaking a large-scale multicentre study comparing the clinical and patient-reported outcomes of oncoplastic breast conservation as an alternative to mastectomy with or without immediate breast reconstruction in women unsuitable for standard breast-conserving surgery (the ANTHEM Feasibility Study).
Davies C; Holcombe C; Skillman J; Whisker L; Hollingworth W; Conefrey C; Mills N; White P; Comins C; Macmillan D; Fairbrother P; Potter S
BMJ Open; 2021 Apr; 11(4):e046622. PubMed ID: 33863715
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
11. Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study.
Stolarz AJ; Lakkad M; Klimberg VS; Painter JT
Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1809-1815. PubMed ID: 31399477
[TBL] [Abstract][Full Text] [Related]
12. Postdiagnostic Calcium Channel Blocker Use and Breast Cancer Mortality: A Population-based Cohort Study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Epidemiology; 2018 May; 29(3):407-413. PubMed ID: 29608546
[TBL] [Abstract][Full Text] [Related]
13. Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes.
Nishida Y; Takahashi Y; Nakayama T; Asai S
Cardiovasc Diabetol; 2012 May; 11():53. PubMed ID: 22594344
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Choksi TT; Zhang H; Chen T; Malhotra N
Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
[TBL] [Abstract][Full Text] [Related]
15. Association Between the Overall Risk of Prostate Cancer and Use of Calcium Channel Blockers: A Systematic Review and Meta-analysis.
Yang H; Yu Y; Hu X; Wang W; Yang X; Liu H; Ren L; Zhang X; Feng X; Liu L
Clin Ther; 2020 Sep; 42(9):1715-1727.e2. PubMed ID: 32807506
[TBL] [Abstract][Full Text] [Related]
16. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
17. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
Tardif JC; Ducharme A; Yu H; Wogen J; Guertin MC
Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.
Wilson LE; D'Aloisio AA; Sandler DP; Taylor JA
Breast Cancer Res; 2016 Jul; 18(1):61. PubMed ID: 27378129
[TBL] [Abstract][Full Text] [Related]
19. The Risk for Prostate Cancer With Calcium Channel Blockers: A Systematic Review, Meta-Analysis, and Meta-Regression.
Rotshild V; Rabkin N; Matok I
Ann Pharmacother; 2023 Jan; 57(1):16-28. PubMed ID: 35645169
[TBL] [Abstract][Full Text] [Related]
20. Australian Suicide Prevention using Health-Linked Data (ASHLi): Protocol for a population-based case series study.
Chitty KM; Schumann JL; Schaffer A; Cairns R; Gonzaga NJ; Raubenheimer JE; Carter G; Page A; Pearson SA; Buckley NA
BMJ Open; 2020 May; 10(5):e038181. PubMed ID: 32398340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
